Home Tags Cancer: Prostate

Tag: Cancer: Prostate

For men with intermediate- and high-risk prostate adenocarcinoma

10-Year Outcomes Similar for H-IMRT, C-IMRT in Prostate Cancer

10-year cumulative incidence of biochemical and/or clinical disease failure no different with C-, H-IMRT
Combined biopsy

Combined Biopsy Method Better for Prostate Cancer Diagnosis

Cancer diagnosed in 9.9 percent more, upgrading seen in 21.8 percent with MRI-targeted + systematic biopsy
Surgical approach is not associated with intermediate-term decision regret following radical prostatectomy

Surgical Approach Not Tied to Decision Regret After Prostatectomy

Functional and oncologic outcomes, autonomous decision-making, and follow-up time influence regret
Statin use alone or in combination with metformin is associated with lower all-cause and prostate cancer mortality among high-risk patients

Statin Use May Reduce Mortality in High-Risk Prostate Cancer

Statin use alone or in combination with metformin tied to lower all-cause, prostate cancer mortality
Most functional differences associated with contemporary management of localized prostate cancer attenuate by five years

Functional Outcomes Similar Across Localized Prostate Cancer Treatments

However, incontinence and sexual function are worse five years following prostatectomy
For men diagnosed with prostate cancer in the Veterans Affairs health system

Outcomes No Worse for Black Veterans With Prostate Cancer

For men in VA health system, blacks do not present with more advanced disease or have higher mortality
There is considerable variation in listed charges for simple intensity-modulated radiation therapy used in prostate cancer treatment

Intensity-Modulated Radiation Charges for Prostate Cancer Vary

Mean charge for standard 28-fraction was $111,728.80, 10.1 times the price paid by Medicare
A behavioral intervention that increases vegetable consumption does not reduce the risk for progression of early-stage prostate cancer

Increasing Vegetable Intake Does Not Slow Prostate Cancer

Behavioral intervention had no impact on time to progression among men with early-stage disease
An artificial intelligence system can be used to detect and grade prostate cancer in prostate needle biopsy samples

AI System Can Detect, Grade Cancer in Prostate Needle Biopsy

AUCs were 0.997, 0.986 for distinguishing between benign, malignant biopsy cores, respectively
Risk-tailored screening could potentially reduce overdiagnosis and improve the cost-effectiveness of a prostate cancer screening program

Risk-Based Approach Could Help Target Prostate Cancer Screening

Risk-based screening yields less overdiagnosis, more cost-effective than age-based screening